Cellular immune response to Borrelia burgdorferi in patients with Lyme borreliosis.
Krause
A
A
Department of Medicine III, University of Erlangen-Nürnberg, Germany.
Rensing
A
A
Kalden
J R
JR
Burmester
G R
GR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015748:Borrelia burgdorferi Group / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007375:Interleukin-1 / Q000096:biosynthesis; D008193:Lyme Disease / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D008213:Lymphocyte Activation; D012016:Reference Values; D013601:T-Lymphocytes / Q000276:immunology*; D016211:Transforming Growth Factor alpha / Q000096:biosynthesis
D000900:Anti-Bacterial Agents; D007375:Interleukin-1; D016211:Transforming Growth Factor alpha